AcuMEMS, a California-based medical device company proclaimed that their company has devised a novel wire-free sensing device for detecting intraocular pressure (IOP) of glaucoma and cataract patients. This innovative sensing device can be implanted at the time of intraocular lens (IOL) surgery for treating cataract by means of an un-enlarged phaco/IOL cut.
Dr. Andrew Iwach, a glaucoma treatment expert and Executive Director at the San Francisco-based Glaucoma Center remarked that, IOP is the only successful treatment criteria and determiner of the spread of glaucoma and that recently, they were able to utilize precise IOP information for safeguarding the vision of patients. He added that, with the advent of this latest system in cataract surgery, they could lower the risk associated with surgical processes and achieve significant benefits.
According to Douglas Lee, Chairman and CEO at AcuMEMS, the advancement of their MEMS wire-free system has provided a great market value for AcuMEMS and will help the surgeons in assisting in the treatment of glaucoma and cataract.
The company’s iSense technology encompasses a series of implantable MEMS sensors which are combined to a handy reader for wire-free and spontaneous monitoring of intraocular pressure (IOP). AcuMEMS is an authorized firm of OrthoMEMS.